Feedback / Questions
SX-682 - Syntrix
Zynyz (retifanlimab-dlwr) - Incyte
Anktiva (nogapendekin alfa inbakicept-pmln) - ImmunityBio
http://clinicaltrials.gov/ct2/show/NCT06149481
Nov 21, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next